Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0859 Dose-Ranging Study in Hypercholesterolemia
NCT00325455Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jun 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of anacetrapib in hypercholesterolemia, mixed hyperlipidemia, sponsored by Merck & Co.. Started Jun 2006; status: terminated.
02
Drugs
anacetrapib
03
Conditions
hypercholesterolemiamixed hyperlipidemia
Beyond the preview
Go deeper on NCT00325455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325455.